Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria.

Authors:

Foss S, Sakya SA, Aguinagalde L, Lustig M, Shaughnessy J, Cruz AR, Scheepmaker L, Mathiesen L, Ruso-Julve F, Anthi AK, Gjølberg TT, Mester S, Bern M, Evers M, Bratlie DB, Michaelsen TE, Schlothauer T, Sok D, Bhattacharya J, Leusen J, Valerius T, Ram S, Rooijakkers SHM, Sandlie I, & Andersen JT.
Journal:

Nat Commun

Year of publication:

2024
Citation:

2024 Mar 7;15(1):2007.

doi:

https://doi.org/10.1038/s41467-024-46321-9
PubMed: PubMed (PMID: 38453922)
Impact factor:

–
Abstract:

–

Participating Institutes